Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 26.55 INR
Change Today -1.25 / -4.50%
Volume 191.3K
CF On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

gufic biosciences ltd (CF) Snapshot

Open
28.80
Previous Close
27.80
Day High
28.80
Day Low
26.40
52 Week High
08/19/15 - 39.60
52 Week Low
03/27/15 - 9.20
Market Cap
2.1B
Average Volume 10 Days
297.1K
EPS TTM
0.49
Shares Outstanding
77.4M
EX-Date
--
P/E TM
54.2x
Dividend
0.05
Dividend Yield
0.19%
Current Stock Chart for GUFIC BIOSCIENCES LTD (CF)

Related News

No related news articles were found.

gufic biosciences ltd (CF) Related Businessweek News

No Related Businessweek News Found

gufic biosciences ltd (CF) Details

Gufic Biosciences Limited manufactures and sells formulations, bulk drugs, and consumer products in India and internationally. The company offers products in various therapeutic segments, including anti-infectives, orthopedic disorders, gynecological disorders, and gastrointestinal disorders. The company develops formulations in various dosage forms, such as tablets, capsules, ointments, creams, gels, liquid syrups, suspensions, emulsions, lotions, solid and liquid injectables, etc. It also provides APIs in the areas of anesthetics, antifungals, anthelmintic, anti-Alzheimer’s, and anti-inflammatory. In addition, the company offers herbal/ayurvedic, consumer, and personal hygiene products, as well as hybrid vegetable seeds. Gufic Biosciences Limited was incorporated in 1984 and is based in Mumbai, India.

Founded in 1984

gufic biosciences ltd (CF) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: 1.5M
Executive Whole Time Director, Member of Audi...
Total Annual Compensation: 86.4K
Compensation as of Fiscal Year 2014.

gufic biosciences ltd (CF) Key Developments

Gufic Biosciences Ltd. to Report Q1, 2016 Results on Aug 14, 2015

Gufic Biosciences Ltd. announced that they will report Q1, 2016 results on Aug 14, 2015

Gufic Biosciences Ltd., Board Meeting, Aug 14, 2015

Gufic Biosciences Ltd., Board Meeting, Aug 14, 2015. Agenda: To consider and approve the unaudited financial results of the company for the quarter ended June 30, 2015.

Gufic Biosciences Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Gufic Biosciences Ltd. reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported total income from operations (net) of INR 355.446 million compared to INR 343.418 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 20.652 million compared to INR 23.856 million a year ago. Profit from ordinary activates before tax was INR 9.993 million compared to INR 13.568 million a year ago. Net profit was INR 11.023 million or INR 0.14 per share compared to INR 6.766 million or INR 0.09 per share a year ago. For the year, the company reported total income from operations (net) of INR 1,517.514 million compared to INR 1,231.450 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 106.148 million compared to INR 96.975 million a year ago. Profit from ordinary activates before tax was INR 65.259 million compared to INR 62.732 million a year ago. Net profit was INR 41.574 million or INR 0.54 per share compared to INR 42.641 million or INR 0.55 per share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CF:IN 26.55 INR -1.25

CF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CF.
View Industry Companies
 

Industry Analysis

CF

Industry Average

Valuation CF Industry Range
Price/Earnings 56.9x
Price/Sales 1.4x
Price/Book 7.7x
Price/Cash Flow 28.0x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUFIC BIOSCIENCES LTD, please visit www.guficbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.